Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Transpl Immunol. 2011 Dec 24;26(2-3):113–118. doi: 10.1016/j.trim.2011.12.006

Table 1.

Absence of acute and chronic cardiac allograft rejection in RAG−/− recipients

Donor Recipient Recipient Treatment Harvest Time (Days) n ARa CRb
B6 RAG−/− B6 RAG−/− None 72 – 75 6 0 0
BALB/c RAG−/− B6 RAG−/− 1×107 B6 T cells i.v.c 11–14d 3 3 0
B10.BR B6 RAG−/− None 79 – 82 7 0 0
B6 RAG−/− BALB/c RAG−/− CFAe 77 – 85 7 0 0
B6 RAG−/− BALB/c RAG−/− Poly I:Cf 60 – 75 4 0 0
B6 RAG−/− BALB/c RAG−/− CpGf 70 – 75 4 0 0
B6 RAG−/− BALB/c RAG−/− B-1 reconstitution 50 (n = 2)
90 (n = 1)
3 0 0
B6 RAG−/− BALB/c RAG−/− Alloimmunizationg 49 – 57
B6 RAG−/− BALB/c RAG−/− Alloimmunization + CFA 48 – 57 7 0 0
a

AR = Acute Rejection

b

. CR = Chronic Rejection.

c

T cells were injected 50 days after transplantation.

d

Hearts were harvested upon cessation of palpable heart beat (median graft survival = 11.5 days after T cell injection) and rejection was confirmed histologically.

e

CFA (200 μl) was administered i.p. 7 days prior to transplantation.

f

Poly I:C (100 μg) and CpG-1826 (25 μg) were administered i.v. on the day of transplantation and once or twice weekly thereafter.

g

Alloimmunization was performed by injecting 2 × 107 B6 RAG−/− splenocytes i.p. 7 days prior to transplantation.